BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 34911362)

  • 1. Detection of Left Atrial Myopathy Using Artificial Intelligence-Enabled Electrocardiography.
    Verbrugge FH; Reddy YNV; Attia ZI; Friedman PA; Noseworthy PA; Lopez-Jimenez F; Kapa S; Borlaug BA
    Circ Heart Fail; 2022 Jan; 15(1):e008176. PubMed ID: 34911362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    Reddy YNV; Obokata M; Verbrugge FH; Lin G; Borlaug BA
    J Am Coll Cardiol; 2020 Sep; 76(9):1051-1064. PubMed ID: 32854840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence-Electrocardiography to Predict Incident Atrial Fibrillation: A Population-Based Study.
    Christopoulos G; Graff-Radford J; Lopez CL; Yao X; Attia ZI; Rabinstein AA; Petersen RC; Knopman DS; Mielke MM; Kremers W; Vemuri P; Siontis KC; Friedman PA; Noseworthy PA
    Circ Arrhythm Electrophysiol; 2020 Dec; 13(12):e009355. PubMed ID: 33185118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining The Risk of Atrial Fibrillation Paroxysm in Patients With Chronic Heart Failure With Intact and Reduced Ejection Fraction.
    Zakharov IP; Chomakhidze PS; Kopylov FY; Sultygova EA; Mesitskaya DF; Lyubimova EA; Andreev DA
    Kardiologiia; 2024 Mar; 64(3):25-33. PubMed ID: 38597759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence-Enabled ECG to Identify Silent Atrial Fibrillation in Embolic Stroke of Unknown Source.
    Rabinstein AA; Yost MD; Faust L; Kashou AH; Latif OS; Graff-Radford J; Attia IZ; Yao X; Noseworthy PA; Friedman PA
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105998. PubMed ID: 34303963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplified P-wave duration predicts new-onset atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Müller-Edenborn B; Minners J; Kocher S; Chen J; Zeh W; Lehrmann H; Allgeier J; Neumann FJ; Arentz T; Jadidi A
    Clin Res Cardiol; 2020 Aug; 109(8):978-987. PubMed ID: 31863175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial Intelligence-Enabled Electrocardiogram for Atrial Fibrillation Identifies Cognitive Decline Risk and Cerebral Infarcts.
    Weil EL; Noseworthy PA; Lopez CL; Rabinstein AA; Friedman PA; Attia ZI; Yao X; Siontis KC; Kremers WK; Christopoulos G; Mielke MM; Vemuri P; Jack CR; Gersh BJ; Machulda MM; Knopman DS; Petersen RC; Graff-Radford J
    Mayo Clin Proc; 2022 May; 97(5):871-880. PubMed ID: 35512882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of New-Onset Atrial Fibrillation in Patients Receiving CRT: Mechanistic Insights From Speckle Tracking Imaging.
    Sade LE; Atar I; Özin B; Yüce D; Müderrisoğlu H
    JACC Cardiovasc Imaging; 2016 Feb; 9(2):99-111. PubMed ID: 26684972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial minimal volume: association with diastolic dysfunction and heart failure in patients in sinus rhythm or atrial fibrillation with preserved ejection fraction.
    Ben-Arzi A; Hazanov E; Ghanim D; Rozen G; Marai I; Grosman-Rimon L; Kachel E; Amir O; Carasso S
    BMC Med Imaging; 2021 May; 21(1):76. PubMed ID: 33957873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of an Artificial Intelligence Enabled Electrocardiogram for Risk Assessment in Liver Transplant Candidates.
    Zaver HB; Mzaik O; Thomas J; Roopkumar J; Adedinsewo D; Keaveny AP; Patel T
    Dig Dis Sci; 2023 Jun; 68(6):2379-2388. PubMed ID: 37022601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.
    Inciardi RM; Giugliano RP; Claggett B; Gupta DK; Chandra A; Ruff CT; Antman EM; Mercuri MF; Grosso MA; Braunwald E; Solomon SD;
    Eur J Heart Fail; 2019 Dec; 21(12):1571-1579. PubMed ID: 31777160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biatrial myopathy in heart failure with preserved ejection fraction.
    Omote K; Sorimachi H; Obokata M; Verbrugge FH; Omar M; Popovic D; Reddy YNV; Pislaru SV; Pellikka PA; Borlaug BA
    Eur J Heart Fail; 2024 Feb; 26(2):288-298. PubMed ID: 38059338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Myopathy in Heart Failure With Preserved Ejection Fraction.
    Omote K; Borlaug BA
    Circ J; 2023 Jul; 87(8):1039-1046. PubMed ID: 34645733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence Application in Graves Disease: Atrial Fibrillation, Heart Failure and Menstrual Changes.
    Naser JA; Attia ZI; Pislaru SV; Stan MN; Pellikka PA; Noseworthy PA; Friedman PA; Lin G
    Mayo Clin Proc; 2022 Apr; 97(4):730-737. PubMed ID: 35078654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction.
    Tamargo M; Obokata M; Reddy YNV; Pislaru SV; Lin G; Egbe AC; Nishimura RA; Borlaug BA
    Eur J Heart Fail; 2020 Mar; 22(3):489-498. PubMed ID: 31908127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of Artificial Intelligence-Enabled Electrocardiography in Patients With Takotsubo Cardiomyopathy.
    Kanaji Y; Ozcan I; Tryon DN; Ahmad A; Sara JDS; Lewis B; Friedman P; Noseworthy PA; Lerman LO; Kakuta T; Attia ZI; Lerman A
    J Am Heart Assoc; 2024 Mar; 13(5):e031859. PubMed ID: 38390798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECG-Based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation.
    Khurshid S; Friedman S; Reeder C; Di Achille P; Diamant N; Singh P; Harrington LX; Wang X; Al-Alusi MA; Sarma G; Foulkes AS; Ellinor PT; Anderson CD; Ho JE; Philippakis AA; Batra P; Lubitz SA
    Circulation; 2022 Jan; 145(2):122-133. PubMed ID: 34743566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Atrial Myopathy in Atrial Fibrillation and Heart Failure: Clinical Implications, Mechanisms, and Therapeutic Targets.
    Peigh G; Shah SJ; Patel RB
    Curr Heart Fail Rep; 2021 Jun; 18(3):85-98. PubMed ID: 33864224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.